Zyprexa (olanzapine) - May 7, 2002
Audience: Pharmacists and Neuro-psychiatric healthcare professionalsEli Lilly notified healthcare professionals of product tampering with Zyprexa, indicated for the treatment of schizophrenia and acute bipolar mania. In a small number of tampering incidents, pharmacists in the United States have found Zyprexa 10 and 15 mg bottles which have had all of the Zyprexa tablets removed and replaced with white tablets marked, "aspirin." The reports, thus far, have been confined to 60 count 10 mg and 15 mg bottles of Zyprexa. These incidents appear to be isolated and limited in scope and no injuries or adverse effects related to the tampering have been reported to date.
[May 4, 2002 Letter: Dear Healthcare Professional - Eli Lilly]
[May 4, 2002 Letter: Dear Pharmacist - Eli Lilly]
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.